CYTOMX THERAPEUTICS INC (CTMX) Stock Cash Flow
NASDAQ:CTMX • US23284F1057
Current stock price
4.52 USD
+0.1 (+2.26%)
At close:
4.521 USD
+0 (+0.02%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -17.37M | 31.87M | -569.00K | -99.30M | -115.90M | |||
| Depreciation Amortization | 1.38M | 1.77M | 2.17M | 2.40M | 2.70M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -68.58M | -126.42M | -62.51M | -30.70M | -22.40M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 8.98M | 6.55M | 4.87M | 16.70M | 16.60M | |||
| OPERATING CASH FLOW | -75.59M | -86.23M | -56.03M | -110.80M | -119.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -220.00K | -310.00K | -840.00K | -1.70M | -1.60M | |||
| Other Investing Activity | -59.52M | 100.01M | -149.83M | 100.00M | 24.10M | |||
| INVESTING CASH FLOW | -59.74M | 99.70M | -150.67M | 98.30M | 22.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 110.45M | 7.52M | 30.23M | N/A | 110.20M | |||
| Other Financing Activity | N/A | N/A | N/A | 600.00K | N/A | |||
| FINANCING CASH FLOW | 110.45M | 7.52M | 30.23M | 600.00K | 110.20M | |||
| CHANGE IN CASH | -24.89M | 20.99M | -176.48M | -11.90M | 13.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -75.59M | -86.23M | -56.03M | -110.80M | -119.00M | |||
| Capital Expenditure | -220.00K | -310.00K | -840.00K | -1.70M | -1.60M | |||
| FREE CASH FLOW | -75.81M | -86.54M | -56.88M | -112.50M | -120.60M | |||
All data in USD